Bone Fracture Healing: Drugs & Supplements Used in India
Bone fracture healing agents used in India: calcium, vitamin D, teriparatide and anti-osteoporotic drugs, sourced from systematic reviews and ICMR data.
This piece covers what each category of fractured bone names actually does biologically, the evidence for using them to speed healing rather than just prevent future fractures, and India's specific nutrient-deficiency context.
Why does vitamin D and calcium status matter for fracture healing?
Calcium and vitamin D are the substrate and hormonal signal, respectively, that bone remodelling depends on, which is why deficiency in either directly impairs a healing fracture's mineralisation. A systematic review of vitamin D supplementation in fracture patients found consistent biological plausibility for benefit, though the size of clinical effect varied across included trials.
India's deficiency burden makes this more than a theoretical concern: a peer-reviewed review found pooled vitamin D deficiency prevalence of approximately 67% across Indian age groups, and a separate long-term nutritional analysis spanning 1963 to 2005 found nutritional bone disease, rickets, osteomalacia and vitamin-D-deficiency osteoporosis together, in 52% of the population studied. Dietary calcium intake in India also runs consistently below the Indian Council of Medical Research's own recommended daily allowance across most surveyed populations.
What is teriparatide, and does it actually speed fracture healing?
Teriparatide is a recombinant fragment of parathyroid hormone that stimulates osteoblast activity, making it an anabolic (bone-building) agent rather than the anti-resorptive mechanism most other osteoporosis drugs use. A systematic review and meta-analysis found a statistically significant reduction in time to fracture union with teriparatide compared to control, a mean difference of just over three days.
The evidence is not uniformly positive across every study design. A separate systematic review of teriparatide's effect on radiographic bone healing found six included studies reporting a positive effect and three reporting no significant radiographic advantage, suggesting the benefit is real but modest and not guaranteed in every fracture pattern or patient. Hypercalcemia is a documented risk when teriparatide is combined with high-dose calcium and vitamin D supplementation, requiring monitoring rather than simply stacking every bone-health intervention together.
How do anti-resorptive drugs fit into fracture healing versus fracture prevention?
Anti-resorptive drugs (bisphosphonates and related agents) work by slowing bone breakdown rather than stimulating new bone formation. That is why their strongest evidence base is fracture prevention in osteoporosis, not accelerating healing of an existing fracture.
Some clinical concern exists around starting anti-resorptive therapy too early after an acute fracture. Suppressing bone turnover during the active remodelling phase could theoretically interfere with healing itself, though the clinical significance of this concern varies by drug and fracture type in the literature.
This is the key distinction that separates the three categories of fractured bone names covered here: nutrient support underpins healing broadly, teriparatide can actively accelerate union in some patients, and anti-resorptive drugs are principally about preventing the next fracture rather than healing the current one.
What regulatory tier do these drugs sit in for Indian pharmacies?
Teriparatide and bisphosphonate-class anti-osteoporotic drugs are prescription-only medicines under Schedule H of the Drugs and Cosmetics Rules 1945, requiring a valid prescription for dispensing. The specific schedule is updated periodically by CDSCO on the Drugs Technical Advisory Board's recommendation.
Calcium and vitamin D supplements, by contrast, are largely available without the same prescription-only restriction in most formulations. That accessibility is part of why deficiency remains widespread despite the products themselves being easy to obtain.
| Category | Example agents | Mechanism | Regulatory tier |
|---|---|---|---|
| Nutrient support | Calcium, vitamin D3 | Substrate and hormonal signal for mineralisation | Largely non-prescription |
| Anabolic | Teriparatide | Stimulates osteoblast bone formation | Schedule H, prescription-only |
| Anti-resorptive | Bisphosphonates and related agents | Slows osteoclast bone breakdown | Schedule H, prescription-only |
Why does hospital pharmacy stocking matter for post-fracture care?
A patient discharged after fracture fixation surgery typically leaves with a nutrient-support prescription and, in select cases, a prescription-only bone agent. If the hospital's own pharmacy doesn't reliably stock either, the patient fills it at an outside chemist, and the treating orthopaedic team loses visibility into whether the patient actually started and continued the regimen that supports their own healing.
Our managed hospital pharmacy services guide covers how an in-house pharmacy keeps that post-fracture medication list filled and visible instead of losing the patient to an outside chemist. Our prescription leakage guide covers what that leakage costs a hospital in both continuity of care and lost revenue. Our pharmacy inventory management guide covers the reorder discipline that keeps both nutrient-support and Schedule H bone agents actually in stock.
Sources
- 1Effectiveness of Teriparatide on Fracture Healing: A Systematic Review and Meta-Analysis — PLOS One
- 2Current Role and Application of Teriparatide in Fracture Healing of Osteoporotic Patients: A Systematic Review — PubMed, National Library of Medicine
- 3The Effect of Vitamin D Supplementation for Bone Healing in Fracture Patients: A Systematic Review — National Institutes of Health, National Library of Medicine
- 4Vitamin D Deficiency in India: Prevalence, Causalities and Interventions — Nutrients (peer-reviewed journal)
- 5Modern India and Dietary Calcium Deficiency — Half a Century Nutrition Data — National Institutes of Health, National Library of Medicine
This article is for informational purposes and is not a substitute for professional medical advice. It describes drug categories and their evidence base for clinical reference; it does not recommend a specific treatment for any individual patient. Consult a qualified orthopaedic specialist for diagnosis and treatment planning.
FAQ
Frequently asked questions
Both are necessary substrates for bone mineralisation, and correcting a deficiency supports healing; the evidence base shows biological plausibility and consistent benefit for correcting deficiency, though effect size varies across trial designs.
No. It is a prescription-only Schedule H drug typically reserved for patients with osteoporotic or delayed-healing fractures where the evidence supports its anabolic effect, not a routine addition to every fracture case.
Pooled prevalence estimates put vitamin D deficiency at roughly 67% across Indian age groups, attributed in the literature to limited sun exposure from lifestyle and clothing patterns, skin pigmentation affecting synthesis, and dietary calcium intake that runs below ICMR's recommended daily allowance in most surveyed populations.
Some clinical concern exists about starting anti-resorptive therapy too early in the active remodelling phase after an acute fracture; timing is typically a decision made by the treating orthopaedic specialist based on fracture type and healing stage.
No. Bisphosphonate-class anti-osteoporotic drugs are prescription-only medicines under Schedule H of the Drugs and Cosmetics Rules 1945 and cannot legally be dispensed without a valid prescription.
Dr. Anurag SharmaMBBS, M.S. Orthopaedics
Consultant Orthopaedic Surgeon
Dr. Anurag Sharma is a Consultant Orthopaedic Surgeon specializing in Joint Replacement & Preservation and Sports Injury & Arthroscopy. He holds an M.S. in Orthopaedics from S.M.S. Medical College, Jaipur, a fellowship in Joint Replacement and Pelvi-acetabular Surgeries under Dr. Ramesh Sen, and an Executive Program in Public Health Policy, Leadership and Management from AIIMS Jodhpur.